Replies to post #772698 on NorthWest Biotherapeutics Inc (NWBO)

[manibiotech]

In my opinion they can argue that they believed that CHM will give favorable recommendation , so they didn' t have to PR till final decision is made . But who knows . They have been behaving as if it is a private company personally owned by them . 

[dennisdave]

NWBO would never try to tie MHRA concerns into an NDA, have it read to a financier, and then attempt to sell stock. Come on. They may be incompetent at (many) times, but they’re not that idiotic.

a. That financier wouldn’t buy any stock so it would not get them anywhere.
b. That financier would dump all their existing shares into the market.
c. That financier would tell their friends, who would also start selling.

This is pure FemIke-level ridiculous reasoning.
It’s nerve-wracking enough waiting for news, but that kind of reasoning from someone else is just idiotic. Trying to claim NWBO is disclosing MHRA concerns under NDA to financiers while also attempting to sell stock? That doesn’t even pass the basic logic test.

[FeMike]

I hope that is not true since I certainly believe it would be considered a material event by everyone since the news of it would certainly impact share price.

The idea that a company is required to PR material news within a given period is a Covid investor stock market myth.

As long as the company can defend why they didn’t PR said material non public info, they are fine. I.e. “an appeal is part of the process; when we got referred to the CHM, it wasn’t a decision. We still believed we would get approval. Nothing had changed with our application status, it was still pending decision, and we clearly stated we would not release updates on the process until a decision was made”

Don’t fool yourself. The company can absolutely defend not announcing a CHM response process.

[Doc logic]

attilathehunt,

Special circumstances with a single product being considered, going concern in all the Qs and current available shares mostly or all spoken and accounted for even if certain workarounds allow for more shares to be issued without covering all potential obligations. These circumstances make a referral to CHM for major issues a material event or at least a gray enough area that a judge could rule either way if not reported as material. That is not something Linda would allow herself to be put in the position of. Best wishes.